Ana Laus to Polymorphism, Single Nucleotide
This is a "connection" page, showing publications Ana Laus has written about Polymorphism, Single Nucleotide.
Connection Strength
0.454
-
de Carvalho AC, Laus AC, Lopes Junior HR, Porto J, Sant'Anna Silva D, Ribeiro AG, Datorre JG, Tavares RM, Sousa Carlos AB, Furquim T, Uno M, Chammas R, Villela P, Dos Reis MB, de Medeiros Matsushita M, Oliveira MA, Hirai WY, Guimar?es DP, Santos FA, Reis RM. Association of Genetic Ancestry and Colorectal Cancer Risk in a Large Brazilian Cohort: Replication of Single-Nucleotide Polymorphisms Identified by Genome-Wide Association Studies. JCO Glob Oncol. 2025 Jun; 11:e2400512.
Score: 0.196
-
De Marchi P, Melendez ME, Laus AC, Kuhlmann PA, de Carvalho AC, Arantes LMRB, Evangelista AF, Andrade ES, de Castro G, Reis RM, Carvalho AL, de Souza Viana L. The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer. Oral Oncol. 2019 11; 98:48-52.
Score: 0.132
-
Laus AC, de Paula FE, de Lima MA, Carlos CD, Gomes INF, de Marchi P, Valente JKN, Pioltini ABM, Miziara JE, da Silva CM, Viana LS, Scapulatempo-Neto C, Reis RM. EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population. Mol Biol Rep. 2019 Apr; 46(2):2417-2425.
Score: 0.127